Results 31 to 40 of about 224,178 (338)

Epidemiology of atopic dermatitis in adults: Results from an international survey

open access: yesAllergy. European Journal of Allergy and Clinical Immunology, 2018
There are gaps in our knowledge of the prevalence of adult atopic dermatitis (AD).
S. Barbarot   +8 more
semanticscholar   +1 more source

Tralokinumab plus topical corticosteroids for the treatment of moderate‐to‐severe atopic dermatitis: results from the double‐blind, randomized, multicentre, placebo‐controlled phase III ECZTRA 3 trial*

open access: yesBritish Journal of Dermatology, 2020
Tralokinumab is a fully human monoclonal antibody that specifically neutralizes interleukin‐13, a key driver of atopic dermatitis (AD).
J. Silverberg   +11 more
semanticscholar   +1 more source

Trial of Nemolizumab and Topical Agents for Atopic Dermatitis with Pruritus.

open access: yesNew England Journal of Medicine, 2020
BACKGROUND Nemolizumab is a subcutaneously administered humanized monoclonal antibody against interleukin-31 receptor A, which is involved in pruritus and inflammation in atopic dermatitis.
K. Kabashima   +3 more
semanticscholar   +1 more source

The Quality of Life of Allergic Cats, Treated with Allergen-Specific Immunotherapy – A Retrospective Study

open access: yesActa Veterinaria, 2023
Feline atopic skin syndrome (FASS) describes allergic skin diseases in cats associated with sensitivity to environmental allergens. Allergen-specific immunotherapy (ASIT) aims to reduce or eliminate symptoms associated with subsequent exposure to the ...
Kotnik Tina, Leder Matic
doaj   +1 more source

Systemic Immunomodulatory Treatments for Atopic Dermatitis

open access: yesJAMA dermatology
Key Points Question What is the relative efficacy and harm of lebrikizumab, the most recently approved biologic medication for atopic dermatitis compared with other systemic treatments?
Aaron M Drucker   +13 more
semanticscholar   +1 more source

Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma.

open access: yesNew England Journal of Medicine, 1992
BACKGROUND In atopic asthma, activated T helper lymphocytes are present in bronchial-biopsy specimens and bronchoalveolar-lavage (BAL) fluid, and their production of cytokines may be important in the pathogenesis of this disorder.
D. Robinson   +8 more
semanticscholar   +1 more source

Morphological patterns of balanoposthitis and their correlation with final etiological diagnosis

open access: yesIndian Dermatology Online Journal, 2023
Background: Balanoposthitis is a common dermatological condition across the globe, but studies describing clinico-morphologic features and their diagnostic correlates are scarce.
Manish Jain   +3 more
doaj   +1 more source

Genetics in Atopic Dermatitis: Historical Perspective and Future Prospects

open access: yesActa Dermato-Venereologica, 2020
Atopic dermatitis (AD) is a common, complex trait, arising from the interplay of multiple genetic and environmental factors. This review provides an overview of developments in the field of AD genetics.
Sara J. Brown, M. S. Elias, M. Bradley
semanticscholar   +1 more source

Risk factors for atopic eczema in school children Fatores de risco para eczema atópico em escolares

open access: yesRevista Brasileira de Saúde Materno Infantil, 2005
OBJECTIVES: to study risk factors related to atopic eczema (AE) in school children of São Paulo. METHODS: 1972 parents or guardians of 6-7 years old children in the Southern Central area of São Paulo answered to a written questionnaire (standardized ...
Gustavo F. Wandalsen   +4 more
doaj   +1 more source

Gender differences in depression and anxiety among atopic dermatitis patients

open access: yesIndian Journal of Dermatology, 2015
Background: Dermatological patients invariably suffer one or the other psychological problems which may escalate to the extent of a mental disorder. One of the most common dermatological disorders is atopic dermatitis (AD), but the literature has limited
Shaily Mina   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy